Literature DB >> 30640024

The prevalence, comorbidity and socio-demographic factors of depressive disorder among Iranian children and adolescents: To identify the main predictors of depression.

Mohammad Reza Mohammadi1, Seyyed Salman Alavi2, Nastran Ahmadi3, Ali Khaleghi4, Koorosh Kamali5, Ameneh Ahmadi6, Zahra Hooshyari7, Fathola Mohamadian8, Nasrin Jaberghaderi9, Marzieh Nazaribadie10, Zahra Sajedi11, Zahra Farshidfar12, Nahid Kaviani13, Reza Davasazirani14, Abdulrahim Jamshidzehi Shahbakhsh15, Mahboubeh Roshandel Rad16, Koroush Shahbazi17, Rohollah Rostami Khodaverdloo18, Leyla Noohi Tehrani19, Mahdie Nasiri20, Fatemeh Naderi21, Arezou Kiani22, Mahboobeh Chegeni23, Seiedeh Maryam Hashemi Nasab24, Mahnaz Ghaneian25, Hosein Parsamehr26, Neda Nilforoushan27, Shahrokh Amiri28, Mahbod Fadaei Fooladi29, Soleiman Mohammadzadeh30, Ahmad Ahmadipour31, Nasrin Sarraf32, Seyed Kaveh Hojjat33, Mehriar Nadermohammadi34, Seyed-Ali Mostafavi35, Hadi Zarafshan36, Maryam Salmanian37, Alia Shakiba38, Simin Ashoori39.   

Abstract

BACKGROUND: Depressive disorders are a major public health problem in developed and developing countries. Recently, several risk factors have been described for depressive disorders in children and adolescents. The aim of the present study was to identify the main risk factors that can affect the incidence of depression in Iranian children and adolescents.
METHODS: A total of 30,546 children and adolescents (between 6 and 18 years of age) participated in a cross-sectional study to identify the predictors of depressive disorders. Depressive disorders were assessed using the Persian version of the Kiddie Schedule for Affective Disorders and Schizophrenia (K-SADS-PL). In addition, a demographic characteristics questionnaire was completed by parents of the participants. The data was analyzed using the SPSS22 software via performing the descriptive analysis and the multiple logistic regression analysis methods. P-values less than 0.05 were considered statistically significant.
RESULTS: Results showed that a higher age (15-18), being female, and the father's unemployment were associated with an increased odds ratio for depressive disorders. The age of 10-14 (OR = 2.1; 95% CI, 1.57-2.81), the age of 15-18 (OR = 4.44; 95% CI, 3.38-5.83), female gender (OR = 1.44; 95% CI, 1.2-1.73) and the father's unemployment (OR = 1.59; 95% CI, 1.01-2.5) were significant positive predictors, whereas, the mother's job (as a housewife) (OR = 0.66; 95% CI, 0.45-0.96) and a history of psychiatric hospitalization of the father and mother (OR = 0.34; 95% CI, 0.15-0.78 and OR = 0.34; 95% CI, 0.14-0.84) were negative predictors for depressive symptoms.
CONCLUSION: Depressive symptoms are common in children and adolescents and are correlated with age and gender. The assessment of the prevalence of psychiatric disorders, especially the depressive disorders and their comorbidities, may help to prevent mood disorders in children and adolescents.
Copyright © 2019. Published by Elsevier B.V.

Entities:  

Keywords:  Children and adolescents; Comorbidity; Depressive symptoms; Prevalence

Mesh:

Year:  2019        PMID: 30640024     DOI: 10.1016/j.jad.2019.01.005

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  7 in total

1.  Social Capital of Parents of Children and Adolescents and Its Relation to Psychiatric Disorders; A Population-Based Study.

Authors:  Mohammad Reza Mohammadi; Rahim Badrfam; Atefeh Zandifar; Nastaran Ahmadi; Ali Khaleghi; Zahra Hooshyari; Seyyed Salman Alavi; Ameneh Ahmadi; Fayegh Yousefi; Nasrin Jaberghaderi; Mehriar Nader-Mohammadi Moghadam; Fathola Mohamadian; Marzieh Nazaribadie; Zahra Sajedi; Zahra Farshidfar; Nahid Kaviani; Reza Davasazirani; Abdulrahim Jamshidzehi Shahbakhsh; Mahboubeh Roshandel Rad; Koroush Shahbazi; Rohollah Rostami Khodaverdiloo; Leyla Noohi Tehrani; Mahdie Nasiri; Fateme Naderi; Arezou Kiani; Mahboobeh Chegeni; Seyedeh Maryam Hashemi Nasab; Mahnaz Ghaneian; Hosien Parsamehr; Neda Nilforoshan; Maryam Salmanian; Hadi Zarafshan
Journal:  Community Ment Health J       Date:  2022-01-15

2.  Disturbance of neurotransmitter metabolism in drug-naïve, first-episode major depressive disorder: a comparative study on adult and adolescent cohorts.

Authors:  Liwei Wang; Ping Yang; Chao Yang; Dong Yang; Xiangxin Wu; Ting Cao; Cuirong Zeng; Qian Chen; Shuangyang Zhang; Zhenyu Zhu; Shimeng Jiao; Hualin Cai
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2022-04-11       Impact factor: 5.760

3.  Epidemiology of Psychotic Disorders Based on Demographic Variables in Iranian Children and Adolescents.

Authors:  Seyyed Salman Alavi; Mohammad Reza Mohammadi; Zahra Hooshyari; Soroush Mohammadi Kalhori; Mona Salehi; Maryam Salmanian; Ali Khaleghi; Hadi Zarafshan; Ameneh Ahmadi; Koorosh Kamali; Nastran Ahmadi
Journal:  Iran J Psychiatry       Date:  2021-01

4.  Addictive Use of Smartphones and Mental Disorders in University Students.

Authors:  Seyyed Salman Alavi; Maryam Ghanizadeh; Malihe Farahani; Fereshteh Jannatifard; Sudeh Esmaili Alamuti; Mohammad Reza Mohammadi
Journal:  Iran J Psychiatry       Date:  2020-04

5.  Psychometric Properties of Mobile Phone Abuse (MPA): Exploratory and Confirmatory Factor Analysis in Student Mobile Users.

Authors:  Seyyed Salman Alavi; Maryam Ghanizadeh; Mohammad Reza Mohammadi; Fereshteh Jannatifard; Mona Salehi; Malihe Farahani; Sudeh Esmaili Alamuti; Hossein Gharaati Sotoudeh; Malek Mirhashemi
Journal:  Iran J Psychiatry       Date:  2021-04

6.  Examining the Effectiveness of a Web-Based Intervention for Depressive Symptoms in Female Adolescents: Applying Social Cognitive Theory.

Authors:  Babak Moeini; Saeed Bashirian; Ali Reza Soltanian; Ali Ghaleiha; Malihe Taheri
Journal:  J Res Health Sci       Date:  2019-08-19

7.  The Effect of Brief Crisis Intervention Package on Improving Quality of Life and Mental Health in Patients with COVID-19.

Authors:  Hossein Gharaati Sotoudeh; Seyyed Salman Alavi; Zari Akbari; Fereshteh Jannatifard; Valentin Artounian
Journal:  Iran J Psychiatry       Date:  2020-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.